After 37 years of pioneering health journalism, community engagement, and empowerment through information, we have now ceased operations.
This website will be accessible until September 2025, with all the information being up to date as of July 2024.
If you are a supplier, or another partner you can contact our legacy email address as aidsmap@outlook.com with any queries.
We extend our heartfelt thanks to everyone who supported our vision for a world where HIV is no longer a threat to health or happiness. Together we have made a difference.
At CROI 2022, Professor Joel Palefsky from the University of California San Francisco talks about the ANCHOR trial, which has showed that screening and early treatment reduces anal cancer in people with HIV.
